Mira Pharmaceuticals (MIRA) Shares Outstanding (2022 - 2025)

Mira Pharmaceuticals has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $23.7 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 43.07% year-over-year to $23.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.7 million (up 43.07% YoY) and the FY2025 annual result came in at $23.7 million, up 43.07% from the prior year.
• Shares Outstanding (Entity) improved to $23.7 million in Q4 2025 per MIRA's latest filing, from $19.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $23.7 million in Q4 2025 and troughed at $13.3 million in Q3 2022.
• A 4-year average of $17.1 million and a median of $17.1 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The widest YoY moves for Shares Outstanding (Entity): up 43.07% in 2025, down 14.69% in 2025.
• Over 4 years, Shares Outstanding (Entity) stood at $17.6 million in 2022, then grew by 5.69% to $18.6 million in 2023, then dropped by 10.8% to $16.6 million in 2024, then jumped by 43.07% to $23.7 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $23.7 million, $19.3 million, and $17.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.